Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

A. De Remigis, T.D. de Gruijl, J.N. Uram, S.C. Tzou, S. Iwama, M.V. Talor, T.D. Armstrong, S.J.A.M. Santegoets, S.F. Slovin, L. Zheng, D.A. Laheru, E.M. Jaffee, W.R. Gerritsen, A.J.M. van den Eertwegh, D.T. Le, P. Caturegli

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)127-137
JournalInternational Journal of Cancer
Volume136
Issue number1
DOIs
Publication statusPublished - 2015

Cite this